Ipca Laboratories Board Meeting Scheduled for 5th Nov'26 to Consider Q2 Results
Ipca Laboratories Ltd 路 Intimation 路 05 Nov 2026, 5:30 am
Ipca Laboratories Board Meeting Scheduled for 5th Nov'26 to Consider Q2 Results Ipca Laboratories Limited announced that its Board of Directors will meet on 5th Nov'26 to consider and approve standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. Additionally, the trading window for dealing in company securities by insiders remains closed from 1st Oct'26 until 7th Nov'26, concluding 48 hours post the declaration of the financial results pursuant to SEBI Insider Trading regulations.
Original exchange filing (PDF)
More announcements from Ipca Laboratories Ltd
- Transcript of Conference Call held on 05.11.2026 路 06 Nov 2026
- Audio Link of Conference Call held on 05.11.2026 路 05 Nov 2026
- Standalone and Consolidated Financial Results for second quarter and half year ended 30.09.2026 路 05 Nov 2026
- Standalone and Consolidated Financial Results for second quarter and half year ended 30.09.2026 路 05 Nov 2026
- Schedule of Conference Call 路 05 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 05 Nov 2026
- Ipca Laboratories Limited has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 05 Nov 2026
- Transcript of Conference Call 路 17 Aug 2026
